The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 29,307 | 1,668,987 | SH | SOLE | 0 | 1,668,987 | 0 | 0 | |
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,633 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 18,205 | 481,094 | SH | SOLE | 0 | 481,094 | 0 | 0 | |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 11,091 | 1,367,582 | SH | SOLE | 0 | 1,367,582 | 0 | 0 | |
| CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 3,412 | 1,617,000 | SH | SOLE | 0 | 1,617,000 | 0 | 0 | |
| CELCUITY INC | COM | 15102K100 | 20,903 | 870,967 | SH | SOLE | 0 | 870,967 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 10,816 | 323,437 | SH | SOLE | 0 | 323,437 | 0 | 0 | |
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 14,901 | 440,869 | SH | SOLE | 0 | 440,869 | 0 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 15,388 | 3,529,465 | SH | SOLE | 0 | 3,529,465 | 0 | 0 | |
| CYTOKINETICS INC | COM NEW | 23282W605 | 13,938 | 704,317 | SH | SOLE | 0 | 704,317 | 0 | 0 | |
| DYNE THERAPEUTICS INC | COM | 26818M108 | 6,420 | 305,125 | SH | SOLE | 0 | 305,125 | 0 | 0 | |
| ESSA PHARMA INC | COM NEW | 29668H708 | 8,054 | 281,911 | SH | SOLE | 0 | 281,911 | 0 | 0 | |
| GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 6,855 | 2,929,447 | SH | SOLE | 0 | 2,929,447 | 0 | 0 | |
| IVERIC BIO INC | COM | 46583P102 | 11,031 | 1,748,241 | SH | SOLE | 0 | 1,748,241 | 0 | 0 | |
| INVENTIVA SA | ADS | 46124U107 | 3,581 | 262,658 | SH | SOLE | 0 | 262,658 | 0 | 0 | |
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,431 | 226,671 | SH | SOLE | 0 | 226,671 | 0 | 0 | |
| KRONOS BIO INC | COM | 50107A104 | 7,157 | 298,839 | SH | SOLE | 0 | 298,839 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 12,958 | 621,493 | SH | SOLE | 0 | 621,493 | 0 | 0 | |
| MACROGENICS INC | COM | 556099109 | 10,579 | 393,850 | SH | SOLE | 0 | 393,850 | 0 | 0 | |
| MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 6,529 | 2,059,729 | SH | SOLE | 0 | 2,059,729 | 0 | 0 | |
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 5,829 | 429,228 | SH | SOLE | 0 | 429,228 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 3,409 | 186,405 | SH | SOLE | 0 | 186,405 | 0 | 0 | |
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 4,270 | 125,000 | SH | SOLE | 0 | 125,000 | 0 | 0 | |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 9,452 | 210,600 | SH | SOLE | 0 | 210,600 | 0 | 0 | |
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 21,832 | 3,096,729 | SH | SOLE | 0 | 3,096,729 | 0 | 0 | |
| SERES THERAPEUTICS INC | COM | 81750R102 | 3,469 | 145,453 | SH | SOLE | 0 | 145,453 | 0 | 0 | |
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 3,001 | 97,143 | SH | SOLE | 0 | 97,143 | 0 | 0 | |
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 10,494 | 3,331,315 | SH | SOLE | 0 | 3,331,315 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,076 | 326,336 | SH | SOLE | 0 | 326,336 | 0 | 0 | |